Stay updated on FF-10101-01 Study in Relapsed AML Clinical Trial
Sign up to get notified when there's something new on the FF-10101-01 Study in Relapsed AML Clinical Trial page.

Latest updates to the FF-10101-01 Study in Relapsed AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page displays Revision: v3.4.2, replacing Revision: v3.4.1.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page. This seems to be a minor site update and does not modify study information.SummaryDifference0.0%

- Check41 days agoChange DetectedThe revision label on the page was updated from v3.3.3 to v3.3.4. No study content or page behavior appears to be altered.SummaryDifference0.0%

- Check62 days agoChange DetectedA consolidated Locations section now lists study sites by state (CA, IL, MD, MA, NY, PA) instead of separate state headers, clarifying where the trial is conducted and improving site visibility.SummaryDifference0.7%

- Check91 days agoChange DetectedAdded a note that PubMed-listed publications are automatically filled and may not all relate to the study; updated the page revision to v3.3.2.SummaryDifference0.1%

- Check98 days agoChange DetectedRemoved the government funding lapse notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to FF-10101-01 Study in Relapsed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FF-10101-01 Study in Relapsed AML Clinical Trial page.